在KPC-Kp感染患者中死亡的结局和预测因子,用梅罗胺治疗Vaborbactam:一项多中心观察性研究
Mario Tumbarello1,2, Francesca Raffaelli3, Maddalena Giannella4
1Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Open forum infectious diseases
|June 10, 2024
概括
梅罗-瓦博巴克坦有效治疗产生KPC的Klebsiella pneumoniae感染,包括对其他药物耐药的感染. 在48小时内提前服用可改善严重病例的存活率.
科学领域:
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
- 临床药理学 临床药理学
背景情况:
- 梅罗-瓦博巴克坦为产生KPC的Klebsiella肺炎 (KPC-Kp) 感染提供了一种新的治疗方法.
- 这包括对Ceftazidime-avibactam耐药的KPC-Kp菌株.
研究的目的:
- 分析KPC-Kp感染中梅罗-瓦博巴克坦的实际使用和结果.
- 确定与接受美罗-瓦博巴克坦治疗的患者30天死亡率相关的因素.
主要方法:
- 从19个意大利医院的观察数据进行了回顾性分析.
- 包括342名患有KPC-Kp感染的成年患者,接受了长达24小时或更长时间的美罗-瓦博巴克坦治疗.
- 使用原始和倾向权重的考克斯回归模型来评估死亡风险因素.
主要成果:
- 30天的死亡率为31.6%.
- 死亡率的独立预测因素包括感染性休克,高查尔森并发症指数,透析和COVID-19.
- 早期 (在48小时内) 服用梅罗-瓦博巴克坦与较低的死亡率有关.
结论:
- 梅罗-瓦博巴克坦在严重的KPC-Kp感染中显示出有效性.
- 这种药物即使作为单疗法使用也有效.
- 早期开始治疗对于改善患者的治疗结果至关重要.
相关概念视频
Pneumonia IV: Management
322
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
Kaplan-Meier Approach
129
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
129


